ASTHMANEFRIN
-
racepinephrine hydrochloride solution
Nephron Pharmaceuticals Corporation
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Warnings
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
AsthmanefrinTM Racepinephrine Inhalation Solution, USP 2.25% is supplied in 0.5 ml sterile unit-of-use vials.
NDC 0487-2784-10 Starter Kit contains 1 EZ Breathe Atomizer and 10 vials, each in an individual foil pouch.
NDC 0487-2784-01 Refill Carton contains 30 vials, each in an individual foil pouch.
Storage and Handling
1-855-999-EZAN (3926)
Monday through Friday, 8:00 a.m. to 5:00 p.m. (Eastern Standard Time).
Manufactured By:
Nephron Pharmaceuticals Corporation
Orlando, FL 32811
Principal Display Panel – Foil Pouch
NDC 0487-2784-10 Starter Kit.
NDC 0487-2784-01 Refill.
AsthmanefrinTM
Racepinephrine Inhalation Solution, USP 2.25%
FOR ORAL INHALATION ONLY
Drug Facts
Active Ingredient: Racepinephrine, USP
Purpose: Bronchodilator
Each 0.5mL contains 11.25mg (as 13.5mg of Racepinephrine HCl, USP).
Uses: For temporary relief of shortness of breath, tightness of chest, and wheezing due to bronchial asthma.
See product carton for detailed information on Uses, Warnings, and Directions.
Other Information: Store at room temperature, between 20° - 25°C (68° and 77°F). Protect from light.
Inactive Ingredients: Ascorbic acid, citric acid, edetate disodium, water for injection.
TAMPER EVIDENT FEATURE:
Do not use this product if the pouch is damaged or torn.
Do not use this product if it is brown in color or cloudy.
STERILE
One 0.5mL Unit-of-Use Vial
Principal Display Panel – Carton (Starter Kit -1 EZ Breathe Atomizer and 10 individually wrapped vials)
NDC 0487-2784-10
AsthmanefrinTM
Racepinephrine Inhalation Solution, USP 2.25%
Bronchodilator
FOR ORAL INHALATION ONLY
TAMPER EVIDENT FEATURE:
Do not use this product if the pouch is damaged or torn.
SULFITE-FREE
PRESERVATIVE-FREE
Neprhon Pharmaceuticals Corporation
Orlando, FL 32811
10 x 0.5mL Sterile Unit-of-Use Vials, each in a foil pouch.
Principal Display Panel – Carton (Refill 30 individually wrapped vials)
NDC 0487-2784-01
AsthmanefrinTM
Racepinephrine Inhalation Solution, USP 2.25%
Bronchodilator
FOR ORAL INHALATION ONLY
TAMPER EVIDENT FEATURE:
Do not use this product if the pouch is damaged or torn.
SULFITE-FREE
PRESERVATIVE-FREE
Neprhon Pharmaceuticals Corporation
Orlando, FL 32811
30 x 0.5mL Sterile Unit-of-Use Vials, each in a foil pouch.
ASTHMANEFRIN
racepinephrine hydrochloride solution |
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part341 | 08/01/2012 |
Labeler - Nephron Pharmaceuticals Corporation (783905201) |
Registrant - Nephron Pharmaceuticals Corporation (783905201) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Nephron Pharmaceuticals Corporation | 783905201 | MANUFACTURE, ANALYSIS, PACK |
Revised: 08/2012 Nephron Pharmaceuticals Corporation